{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T22:41:48Z","timestamp":1790030508994,"version":"4.0.1"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100007543","name":"Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des Produits de Sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.seizure.2019.07.007","type":"journal-article","created":{"date-parts":[[2019,7,8]],"date-time":"2019-07-08T11:31:10Z","timestamp":1562585470000},"page":"71-76","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Trends in sodium valproate prescriptions among children aged 0 to 14 years between 2010 and 2016: A study based on the French National Health Insurance Database"],"prefix":"10.1016","volume":"70","author":[{"given":"Elisabeth","family":"Polard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adeline","family":"Degremont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Rault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9ranger","family":"Le Nautout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Oger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Biraben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Nowak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.seizure.2019.07.007_bib0005","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1468-1331.2004.00992.x","article-title":"The epidemiology of epilepsy in Europe \u2013 a systematic review","volume":"12","author":"Forsgren","year":"2005","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.seizure.2019.07.007_bib0010","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0887-8994(97)00154-9","article-title":"Epidemiology of epilepsy in childhood: a cohort of 440 consecutive patients","volume":"18","author":"Kramer","year":"1998","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.seizure.2019.07.007_bib0015","first-page":"1395","article-title":"[Medical treatment of pediatric epilepsy]","volume":"62","author":"Chiron","year":"2012","journal-title":"Rev Prat"},{"issue":"Suppl 1","key":"10.1016\/j.seizure.2019.07.007_bib0020","first-page":"S26","article-title":"Pediatric epilepsy syndromes: an update and critical review","volume":"37","author":"Duchowny","year":"1996","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2019.07.007_bib0025","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1111\/j.1468-1331.2007.01970.x","article-title":"Prescribing patterns of antiepileptic drugs in Italy: a nationwide population-based study in the years 2000\u20132005","volume":"14","author":"Savica","year":"2007","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.seizure.2019.07.007_bib0030","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.eplepsyres.2011.02.012","article-title":"Prescription patterns of antiepileptic drugs in patients with epilepsy in a nation-wide population","volume":"95","author":"Johannessen Landmark","year":"2011","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.seizure.2019.07.007_bib0035","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1136\/adc.2008.144386","article-title":"Changing trends in antiepileptic drug prescribing in girls of child-bearing potential","volume":"94","author":"Ackers","year":"2009","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.seizure.2019.07.007_bib0040","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.yebeh.2009.04.026","article-title":"Antiepileptic drug use in women of childbearing age","volume":"15","author":"Meador","year":"2009","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2019.07.007_bib0045","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.seizure.2012.04.014","article-title":"Trends in antiepileptic drug utilisation in UK primary care 1993\u20132008: Cohort study using the general practice research database","volume":"21","author":"Nicholas","year":"2012","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2019.07.007_bib0050","series-title":"Valproate and its derivatives : risk of abnormal pregnancy outcomes - Dear Doctor Letter","author":"French Agency for the Safety of Medicines and Health Products","year":"2014"},{"key":"10.1016\/j.seizure.2019.07.007_bib0055","series-title":"Monotherapy treatment of epilepsy in pregnancy: congenital malformation outcomes in the child. Cochrane database of systematic reviews","author":"Weston","year":"2016"},{"key":"10.1016\/j.seizure.2019.07.007_bib0060","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.reprotox.2016.06.007","article-title":"The treatment of epilepsy in pregnancy: the neurodevelopmental risks associated with exposure to antiepileptic drugs","volume":"64","author":"Bromley","year":"2016","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.seizure.2019.07.007_bib0065","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1001\/jama.2013.2270","article-title":"Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism","volume":"309","author":"Christensen","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.seizure.2019.07.007_bib0070","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ntt.2016.01.001","article-title":"Behavioral outcomes in children exposed prenatally to lamotrigine, valproate, or carbamazepine","volume":"54","author":"Deshmukh","year":"2016","journal-title":"Neurotoxicol Teratol"},{"key":"10.1016\/j.seizure.2019.07.007_bib0075","series-title":"New prescription and delivery conditions for valproate and its derivatives linked to the risks associated to their use during pregnancy - Dear Doctor Letter","author":"French Agency for the Safety of Medicines and Health Products","year":"2015"},{"key":"10.1016\/j.seizure.2019.07.007_bib0080","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.seizure.2014.08.006","article-title":"Withholding the choice of sodium valproate to young women with generalised epilepsy: are we causing more harm than good?","volume":"24","author":"Mole","year":"2015","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2019.07.007_bib0085","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1002\/pds.3763","article-title":"Compliance with pregnancy prevention plan recommendations in 8672 French women of childbearing potential exposed to acitretin","volume":"24","author":"Raguideau","year":"2015","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.seizure.2019.07.007_bib0090","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1002\/pds.3879","article-title":"Brand name to generic substitution of antiepileptic drugs does not lead to seizure-related hospitalization: a population-based case-crossover study","volume":"24","author":"Polard","year":"2015","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.seizure.2019.07.007_bib0095","series-title":"Exposition \u00e0 l\u2019acide valpro\u00efque et ses d\u00e9riv\u00e9s au cours de la grossesse en France de 2007 \u00e0 2014: une \u00e9tude observationnelle sur les donn\u00e9es du SNIIRAM","author":"French Agency for the Safety of Medicines and Health Products","year":"2016"},{"key":"10.1016\/j.seizure.2019.07.007_bib0100","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.seizure.2013.09.007","article-title":"Trends in the first antiepileptic drug prescribed for epilepsy between 2000 and 2010","volume":"23","author":"Pickrell","year":"2014","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2019.07.007_bib0105","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1600-0404.2006.00639.x","article-title":"Trends in utilization of antiepileptic drugs in Denmark","volume":"113","author":"Tsiropoulos","year":"2006","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.seizure.2019.07.007_bib0110","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.eplepsyres.2009.07.005","article-title":"Antiepileptic drugs in epilepsy and other disorders\u2014a population-based study of prescriptions","volume":"87","author":"Johannessen Landmark","year":"2009","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.seizure.2019.07.007_bib0115","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/pds.1871","article-title":"Antiepileptic drugs in Australia: 2002\u20132007","volume":"19","author":"Hollingworth","year":"2010","journal-title":"Pharmacoepidem Drug Safe"},{"key":"10.1016\/j.seizure.2019.07.007_bib0120","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1111\/j.1528-1167.2010.02546.x","article-title":"Course and outcome of childhood epilepsy: a 15-year follow-up of the Dutch study of epilepsy in childhood","volume":"51","author":"Geerts","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2019.07.007_bib0125","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.eplepsyres.2015.11.012","article-title":"Pharmacological outcomes in juvenile myoclonic epilepsy: support for sodium valproate","volume":"119","author":"Chowdhury","year":"2016","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.seizure.2019.07.007_bib0130","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.seizure.2007.02.006","article-title":"Clinical use of antiepileptic drugs at a referral centre for epilepsy","volume":"16","author":"Landmark","year":"2007","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2019.07.007_bib0135","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.eplepsyres.2010.08.002","article-title":"Patterns of prescription of antiepileptic drugs in patients with refractory epilepsy at tertiary referral centres in Italy","volume":"91","author":"Malerba","year":"2010","journal-title":"Epilepsy Res"}],"container-title":["Seizure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131118307921?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131118307921?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T01:52:20Z","timestamp":1761011540000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131118307921"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":27,"alternative-id":["S1059131118307921"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2019.07.007","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trends in sodium valproate prescriptions among children aged 0 to 14 years between 2010 and 2016: A study based on the French National Health Insurance Database","name":"articletitle","label":"Article Title"},{"value":"Seizure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2019.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 British Epilepsy Association. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}